Therefore, the observed upregulation of CXCL10, driven by tumor-intrinsic IFNα and potentially mediated by M1 polarization, likely plays a crucial role in facilitating the recruitment and activation of CD8+ T cells, thereby enhancing the efficacy of immunotherapeutic interventions targeting PD-(L)1. Here, CXCL10 is linked to neoplasm.